Back
Lineage Cell Therapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
47
LCTX
Lineage Cell Therapeutics
Last Price:
$0.66
Seasonality Move:
-4.5%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is moderately bullish and LCTX is experiencing slight selling pressure.
Lineage Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Buy |
| 20-day SMA: | 0.54 | Buy |
| 50-day SMA: | 0.49 | Buy |
| 200-day SMA: | 0.66 | Sell |
| 8-day EMA: | 0.64 | Buy |
| 20-day EMA: | 0.57 | Buy |
| 50-day EMA: | 0.53 | Buy |
| 200-day EMA: | 0.66 | Buy |
Lineage Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 67.8 | Buy |
| Chaikin Money Flow: | -311574 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.62) | Buy |
| Bollinger Bands (100): | (0.45 - 0.63) | Buy |
Lineage Cell Therapeutics Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics Stock
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.66 while LCTX 8-day simple moving average is 0.65, which is a Buy signal.
-
The stock price of LCTX is 0.66 while Lineage Cell Therapeutics 20-day SMA is 0.54, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day simple moving average is 0.49 while LCTX share price is 0.66, making it a Buy technically.
-
LCTX stock price is 0.66 and Lineage Cell Therapeutics 200-day simple moving average is 0.66, creating a Sell signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
47
Lineage Cell Therapeutics (LCTX)
is a Sell
Is Lineage Cell Therapeutics a Buy or a Sell?
-
Lineage Cell Therapeutics stock is rated a SellThe current Lineage Cell Therapeutics [LCTX] share price is $0.66. The Score for LCTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics Stock Info
Market Cap:
150.3M
Price in USD:
0.66
Share Volume:
672.8K
Lineage Cell Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.37
Sell
47
Lineage Cell Therapeutics (LCTX)
is a Sell
Lineage Cell Therapeutics Share Price Forecast
-
What is the Lineage Cell Therapeutics stock price today?The Lineage Cell Therapeutics stock price is 0.66 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics is overvalued.
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.66 while LCTX 8-day exponential moving average is 0.64, which is a Buy signal.
-
The stock price of LCTX is 0.66 while Lineage Cell Therapeutics 20-day EMA is 0.57, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day exponential moving average is 0.53 while LCTX share price is 0.66, making it a Buy technically.
-
LCTX stock price is 0.66 and Lineage Cell Therapeutics 200-day simple moving average is 0.66, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics
Is Lineage Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.
Technical Analysis of Lineage Cell Therapeutics
Should I short Lineage Cell Therapeutics stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Lineage Cell Therapeutics is a Buy
-
Lineage Cell Therapeutics Relative Strength Index (RSI) is 67.8, which suggest Lineage Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Lineage Cell Therapeutics is (0.44 - 0.62), which suggest Lineage Cell Therapeutics is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics is (0.45 - 0.63), which suggest Lineage Cell Therapeutics is a Buy
* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.